Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-08-25

Clinical Trial Update: Extract of Curcuma Longa Complexed With Phosphatidilcholine(Motore®)in the Treatment of Adults With Knee Osteoarthritis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating Motore, an extract of Curcuma longa complexed with phosphatidylcholine, for knee osteoarthritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Motore (Curcuma longa extract complexed with phosphatidylcholine)

Snippet

Sponsor: Ache Laboratorios Farmaceuticos S.A. | Conditions: Osteoarthritis, Knee | Phase 4 | Status: COMPLETED